Medy-Tox Inc. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
18,019
51,072
76,937
29,337
33,368
Total Accounts Receivable
10,936
47,427
18,855
31,563
56,004
Inventories
1,704
3,772
5,842
6,879
11,609
Other Current Assets
716
976
1,846
819
2,173
Total Current Assets
31,374
103,247
103,481
68,598
103,154
Net Property, Plant & Equipment
35,752
50,981
81,018
150,553
184,391
Total Investments and Advances
161
1,883
6,350
72,262
68,904
Long-Term Note Receivable
195
218
33
31
28
Intangible Assets
7,781
9,906
10,307
19,311
28,441
Other Assets
2,088
684
-
2,567
2,094
Total Assets
79,414
168,511
203,552
324,030
389,129
ST Debt & Current Portion LT Debt
8,488
8,443
25,092
39,757
99,234
Accounts Payable
99
858
1,744
2,632
1,684
Income Tax Payable
1,632
8,155
6,071
18,339
17,202
Other Current Liabilities
4,177
17,540
14,628
15,834
19,270
Total Current Liabilities
14,395
34,997
47,535
76,561
137,389
Long-Term Debt
-
-
-
61,753
15,000
Provision for Risks & Charges
968
1,702
2,568
1,739
1,689
Deferred Taxes
2,064
1,592
2,364
10,709
2,118
Other Liabilities
2,972
49,616
39,423
36,221
30,183
Total Liabilities
18,335
86,314
89,526
176,275
184,261
Common Equity (Total)
60,685
81,590
113,483
147,679
199,838
Total Shareholders' Equity
60,685
81,590
113,483
147,679
199,838
Total Equity
60,685
81,590
113,483
147,679
204,710
Liabilities & Shareholders' Equity
79,414
168,511
203,552
324,030
389,129
Accumulated Minority Interest
-
-
-
-
4,872
Non-Equity Reserves
394
607
543
77
158

About Medy-Tox

View Profile
Address
78 Gangni 1-gil
Cheongju-si NC 28126
Korea, Republic Of
Employees -
Website http://www.medy-tox.co.kr
Updated 09/14/2018
Medy-Tox, Inc. engages in the manufacture and sale of biopharmaceutical products. Its products include botulinum toxin, hyaluronic acid filler, medical devices, toxin detection kit and antitoxin therapeutics. The company was founded on May 2, 2000 and is headquartered in Cheongju-si, South Korea.